The cause of Alzheimer's disease is still unknown, but the disease is distinctively characterized by the accumulation of β-amyloid plaques and neurofibrillary tangles in the brain. These features have become the primary focus of much of the research looking for new treatments for the disease, including immunotherapy and vaccines targeting β-amyloid in the brain. Adverse effects observed in a clinical trial based on the β-amyloid protein were attributed to the presence of the target antigen and emphasized the relevance of finding safer antigen candidates for active immunization. For this kind of approach, different vaccine formulations using DNA, peptide, and heterologous prime-boost immunization regimens have been proposed. Promising results are expected from different vaccine candidates encompassing B-cell epitopes of the β-amyloid protein. In addition, recent results indicate that targeting another protein involved in the etiology of the disease has opened new perspectives for the effective prevention of the illness. Collectively, the evidence indicates that the idea of finding an effective vaccine for the control of Alzheimer's disease, although not without challenges, is a possibility.

Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is an emergent pathogen in Brazil. However, there are no data on the prevalence of CA-MRSA. We report here the first well-characterized case of severe life-threatening CA-MRSA infection in a child living in Rio de Janeiro city. The patient had many complications including hematogenous osteomyelitis and involvement of multiple sites requiring drainage of soft-tissue abscess, and pleural and pericardial empyema. The MRSA isolates recovered were genotyped using PFGE, SCCmec typing and multilocus sequence typing. Disk diffusion tests were performed following Clinical and Laboratory Standards Institute recommendations. In addition, the presence of Panton-Valentine leukocidin (PVL) was assessed by PCR amplification, using specific primers for lukF-pv (encoding for the F subunit of the PVL). The bacterial isolates were related to the ST30-SCCmecIV lineage (Oceania Southwest Pacific clone), a PVL producer CA-MRSA previously detected in Porto Alegre, RS, Brazil. Also, the isolates analyzed were susceptible to all non-β-lactam antibiotics tested. The present report demonstrates that disseminated CA-MRSA disease is also occurring in Rio de Janeiro. Thus, the empirical treatment of moderate or severe infections suspected of being associated with CA-MRSA needs to be reviewed in order to allow prompt initiation of an effective therapy that also covers these microorganisms.

O herbicida sistêmico imazapyr foi usado no controle da taboa (Typha subulata Crespo & Peres-Moreau f.) em drenos de irrigação, como alternativa ao controle mecânico. O resíduo do princípio ativo do herbicida na água foi analisado por cromatografia líquida de alta performance (HPLC). A curva de dissipação de imazapyr mostrou que o herbicida pode ser usado para o controle de taboa em drenos de irrigação, sem causar danos a culturas vizinhas, desde que a água seja usada, no mínimo, depois de 1,6 a 3,7 dias da aplicação das doses de 500 a 1500 g ha-1, respectivamente.

Imazapyr, a systemic herbicide, was used to control cattail (Typha subulata Crespo & Peres-Moreau f.) in irrigation project drains as an alternative for mechanical control. Residue of this herbicide was analysed in water by high performance liquid chromatography (HPLC). Imazapyr dissipation curve with applied doses ranging from 500 to 1500 g ha-1 showed that it could be used to control cattail without injuring neighbor crops, as long as water drain be used at least 1.6 to 3.7 days after application.